I urge you to do your own due diligence on the costs before starting treatment. My doc's office made assurances too - but it didn't pan out. All their insurance person can do (which I do understand) is share all suggestions/contact info they have for pharma company and other available financial avenues - but that doesn't mean you'll qualify - or that what's available will cover enough to still be doable for you.

Case in point: I have commercial insurance through my employer. I had to pay full retail price of $2700/month until I met my deductible. Then $700/month AFTER I met my insurance deductible. I was able to get Tymlos help to cover majority of 1st year, with a few months out of pocket. But now Radius tells me I may not get a 2nd card for Year 2. This floored me: why aren't they transparent about that upfront? Seems misleading to start a patient on a 2-year regimen with promise of financial help, then cut them off after year 1, halfway thru treatment.

I'll mostly likely have to abort and just switch to a maintenance drug next year. I wouldn't want anyone else to find themselves in that position.

Definitely check the financial end yourself: the doc's staff can definitely help, but they can't really promise anything.